Frederick Keeney

962 total citations
8 papers, 196 citations indexed

About

Frederick Keeney is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Frederick Keeney has authored 8 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Frederick Keeney's work include Mitochondrial Function and Pathology (2 papers), Cell Adhesion Molecules Research (2 papers) and Melanoma and MAPK Pathways (2 papers). Frederick Keeney is often cited by papers focused on Mitochondrial Function and Pathology (2 papers), Cell Adhesion Molecules Research (2 papers) and Melanoma and MAPK Pathways (2 papers). Frederick Keeney collaborates with scholars based in United States, Austria and Denmark. Frederick Keeney's co-authors include Meenhard Herlyn, Adina Vultur, Melissa Wilson, James E. Hayden, Qing Chen, Gunesh P. Rajan, Min Xiao, Phyllis A. Gimotty, James Hayden and Jessie Villanueva and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Cell Science.

In The Last Decade

Frederick Keeney

8 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick Keeney United States 5 134 104 28 27 25 8 196
Irene Riz United States 10 257 1.9× 78 0.8× 37 1.3× 37 1.4× 30 1.2× 13 315
Peter J. Volberding United States 8 94 0.7× 43 0.4× 23 0.8× 53 2.0× 14 0.6× 9 192
Lars A.T. Meijer Netherlands 8 310 2.3× 91 0.9× 18 0.6× 30 1.1× 43 1.7× 8 362
Jacob V. Layer United States 7 100 0.7× 40 0.4× 15 0.5× 23 0.9× 24 1.0× 11 176
Verónica Rendo Sweden 8 315 2.4× 76 0.7× 24 0.9× 22 0.8× 23 0.9× 16 382
Marius S. Pop United States 6 205 1.5× 74 0.7× 17 0.6× 21 0.8× 46 1.8× 9 254
Phaedra C. Ghazi United States 8 91 0.7× 44 0.4× 33 1.2× 29 1.1× 13 0.5× 9 169
Florian Baumgartner Austria 6 268 2.0× 90 0.9× 40 1.4× 58 2.1× 36 1.4× 8 311
Sasha Pantel United States 4 303 2.3× 65 0.6× 19 0.7× 16 0.6× 11 0.4× 4 336
Mobeen Malik United States 6 260 1.9× 127 1.2× 16 0.6× 54 2.0× 17 0.7× 7 342

Countries citing papers authored by Frederick Keeney

Since Specialization
Citations

This map shows the geographic impact of Frederick Keeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Keeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Keeney more than expected).

Fields of papers citing papers by Frederick Keeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Keeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Keeney. The network helps show where Frederick Keeney may publish in the future.

Co-authorship network of co-authors of Frederick Keeney

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Keeney. A scholar is included among the top collaborators of Frederick Keeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Keeney. Frederick Keeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Poli, Adi Narayana Reddy, Ian Tietjen, Nitesh Kumar Nandwana, et al.. (2024). Design of novel and highly selective SARS-CoV-2 main protease inhibitors. Antimicrobial Agents and Chemotherapy. 68(10). e0056224–e0056224. 2 indexed citations
2.
Bertolini, Irene, Ekta Agarwal, Jagadish C. Ghosh, et al.. (2023). Parkin ubiquitination of Kindlin-2 enables mitochondria-associated metastasis suppression. Journal of Biological Chemistry. 299(6). 104774–104774. 3 indexed citations
3.
Brooks, Rebekah, Xue Zhang, Andrew V. Kossenkov, et al.. (2022). Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis. Cell Reports. 41(3). 111514–111514. 7 indexed citations
4.
Bertolini, Irene, Frederick Keeney, & Dario C. Altieri. (2021). Protocol for assessing real-time changes in mitochondrial morphology, fission and fusion events in live cells using confocal microscopy. STAR Protocols. 2(3). 100767–100767. 4 indexed citations
5.
Leo, Alessandra De, Zhong Deng, Olga Vladimirova, et al.. (2019). LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency. PLoS Pathogens. 15(1). e1007489–e1007489. 26 indexed citations
6.
Deng, Zhong, et al.. (2019). PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly. Journal of Cell Science. 132(6). 20 indexed citations
7.
Perego, Michela, Sydney M. Shaffer, André C. Müller, et al.. (2017). A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene. 37(3). 302–312. 61 indexed citations
8.
Vultur, Adina, Jessie Villanueva, Clemens Krepler, et al.. (2013). MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines. Oncogene. 33(14). 1850–1861. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026